Literature DB >> 12152152

Techniques of laparoscopic Roux-en-Y gastric bypass.

Mohamed R Ali1, Harvey J Sugerman, Eric J DeMaria.   

Abstract

Morbid obesity represents a challenge to healthcare as the underlying source of numerous risks and significant expenditure. Gastric bypass surgery has been validated as a means of significant and reproducible reduction in weight. In the laparoscopic era, the minimally invasive approach has been applied to this procedure with promising results. In our technique, we divide the stomach to create a small gastric pouch drained by a retrocolic, retrogastric Roux-en-Y alimentary jejunal limb. The gastrojejunostomy is performed in 2 layers, an inner stapled layer and an outer sutured layer. We, like other groups, have found that laparoscopic gastric bypass provides similar efficacy to open gastric bypass, but offers improved patient acceptance, quality of life, and significantly less wound complications. Copyright 2002, Elsevier Science (USA). All rights reserved.

Entities:  

Mesh:

Year:  2002        PMID: 12152152

Source DB:  PubMed          Journal:  Semin Laparosc Surg        ISSN: 1071-5517


  3 in total

1.  Obesity surgery: evidence-based guidelines of the European Association for Endoscopic Surgery (EAES).

Authors:  S Sauerland; L Angrisani; M Belachew; J M Chevallier; F Favretti; N Finer; A Fingerhut; M Garcia Caballero; J A Guisado Macias; R Mittermair; M Morino; S Msika; F Rubino; R Tacchino; R Weiner; E A M Neugebauer
Journal:  Surg Endosc       Date:  2004-12-02       Impact factor: 4.584

Review 2.  The ABC System: a simplified classification system for small bowel obstruction after laparoscopic Roux-en-Y gastric bypass.

Authors:  Olga N Tucker; Tomas Escalante-Tattersfield; Samuel Szomstein; Raul J Rosenthal
Journal:  Obes Surg       Date:  2007-11-27       Impact factor: 4.129

Review 3.  Surgery for obesity: a review of the current state of the art and future directions.

Authors:  Stephen S McNatt; James J Longhi; Charles D Goldman; David W McFadden
Journal:  J Gastrointest Surg       Date:  2007-03       Impact factor: 3.267

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.